Skip to Main content Skip to Navigation
Master Thesis

Impact de l'affaire du Levothyrox sur le pharmacien d'officine en Nouvelle Aquitaine

Abstract : In 2017 Merck, with the advices of the ANSM, changed the formulation of the Levothyrox®: the medicine uses to treat hypothyroidism. This change has done a huge increase of side effects declarations at the ARS (health regional agencies) and the mediatisation leads to what we know today as: “the Levothyrox® affair”. So, I made an anonymous survey for Nouvelle Aquitaine officinal pharmacists to know what was the impact of this affair in their missions and also in the patient care and following. Clinical pharmacy is not really used in town pharmacy, the development of this part of pharmacy could help pharmacists to improve the security of their patients in the health care way in crisis like this one.
Document type :
Master Thesis
Complete list of metadata

https://dumas.ccsd.cnrs.fr/dumas-03244307
Contributor : Odonto Ub - Connect in order to contact the contributor
Submitted on : Tuesday, June 1, 2021 - 10:44:56 AM
Last modification on : Thursday, July 8, 2021 - 3:16:00 AM
Long-term archiving on: : Thursday, September 2, 2021 - 6:25:04 PM

File

Pharmacie_2021_Nicolescu-Catar...
Files produced by the author(s)

Identifiers

  • HAL Id : dumas-03244307, version 1

Collections

Citation

Pierre Nicolescu-Catargi. Impact de l'affaire du Levothyrox sur le pharmacien d'officine en Nouvelle Aquitaine. Sciences du Vivant [q-bio]. 2021. ⟨dumas-03244307⟩

Share

Metrics

Record views

43

Files downloads

32